The Malaysian medicine register — in the present tense
Friday, 17 July 2026
Every medicine in Malaysia, made legible.
The complete register — every molecule’s makers, market size, patent status, and
registration pathway, in one place. The facts NPRA holds, finally readable, the same for
everyone. A neutral reference for anyone weighing entry into the Malaysian market.
The register, at a glance.
Of the 72 molecules tracked most closely, grouped by market structure — a neutral count of makers and patent status. No verdict; just the shape of the register today.
12 generic-open
8 near cliff
22 multi-source
30 patent-protected
Generic-open — off-patent, generics registered
Near cliff — patent expiry within 24 months
Multi-source — 10+ registered makers
Patent-protected — single maker
The atlas — Malaysia, state by state.
Diabetes prevalence by state, against the national 18.3% line — where the patients behind every metabolic door actually are. One layer of many: supply, procurement and access map the same way.
Below nationalAbove national
Illustrative — state-level diabetes prevalence (NHMS-shaped) vs the national 18.3%. Boundaries: DOSM open geodata.